⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 16, 2024Gynecologic OncologyOpen Access

Brachytherapy in vaginal cancer for organ preservation: Clinical outcome and safety from a single center experience

Ricarda Merten Vratislav Strnad Andre Karius Michael Lotter Stephan Kreppner Claudia Schweizer Rainer Fietkau Philipp Schubert

View Full Paper

Ask AI

Bookmark

Share

Abstract

Interstitial and/or intracavitary brachytherapy is an integral part of the treatment of vaginal cancer Brachytherapy (BT) has shown to improve local control, overall survival (OS) and disease-free survival (DFS). The aim of our study was to analyze the efficacy and safety of brachytherapy in patients with vaginal cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Merten et al. (2024) studied this question.

synapsesocial.com/papers/68e5bfacb6db64358755781e https://doi.org/10.1016/j.ygyno.2024.07.683

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Brachytherapy in vulvar cancer: Clinical outcome and safety from a single center experience.Human Clinical Trial · 2026 · 1 citations
2Supportive Care for HDR Brachytherapy in Gynecological Cancer: A Single Center ExperienceRetrospective Study · 2026 · 1 citations
3Comparision of Intravaginal with Interstitial Brachytherapy in Cervical Cancer after Inadvertent Hysterectomy: A Retrospective Study2024
4High-dose-rate vaginal brachytherapy for treatment of recurrent high-grade vaginal intraepithelial neoplasiaCohort Study · 2026
5Image-guided adaptive interventional radiotherapy (modern brachytherapy) boost for vaginal recurrencesCohort Study · 2026